CYP4A2 Antibodies

Santa Cruz Biotechnology provides a broad selection of CYP4A2 monoclonal antibodies for research focused on understanding this important enzyme. CYP4A2 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP4A2 is a member of the cytochrome P450 family, which plays a crucial role in the metabolism of fatty acids and the synthesis of bioactive lipids. CYP4A2 actively participates in the regulation of blood pressure and inflammation, making it a significant target for studies related to cardiovascular health and metabolic disorders. Understanding CYP4A2 function can provide insights into various physiological processes and disease mechanisms. Researchers worldwide rely on CYP4A2 monoclonal antibodies to advance their studies in fatty acid metabolism and bioactive lipid synthesis. CYP4A2 research has revealed important connections between lipid metabolism and cardiovascular health, opening new avenues for therapeutic development. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific understanding of CYP4A2's role in human health and disease.